Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by SizzlinSteakson Mar 17, 2018 4:19pm
154 Views
Post# 27734244

RE:This week will be massive for the company

RE:This week will be massive for the companyWell I’ll said and I agree. Well worth the risk. Based on all historical trials for ATB-346 everything indicates results should be positive.


WaterStreet87 wrote: If the trial is successful, insitutions will load and retail will have little effect on this play.  Management has been quoted many times if the trial is successful they'll sell to a major pharma as they should considering the impact it would have.

The board is quite something, nobel prize winners, Mastercard executive and plenty of more achievements - they're all banking on this week.  

Unfortunately no matter what is said here, good or bad it won't have an effect on the SP.  The trial results is what folks are waiting on.  I'm banking on tuesday we get halted and updated wednesday.  I have 45k shares and personally will triple up if successful and hold for a few years.

So again, if successful this stock will change quite a few lives and if not it will unfortunately head to it's lows of 20 cents again.  It's worth the gamble here IMO as not often you get penny stocks with this potential.

Water


Bullboard Posts